Japan's Kowa says ivermectin showed antiviral effect against Omicron in research

reuters.com

There is no story here. They have published nothing, and they didn't even do a clinical study.

> "Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an 'antiviral effect' against Omicron and other variants of coronavirus in joint non-clinical research."

actually on the other thread there was a link to a small phase III trial (double blind, but I didn't inspect the details).

Non-clinical research means what exactly? They read a bunch of articles/papers/news articles?

Reply on news.ycombinator.com